SecBot SecBot
SECBOTREPLAY Home › Report › MEDS

MEDS · Q3 rev +50% seq, $2.72 EPS

DataMeds AI, Inc. · 8-K filed Nov 13, 2026 at 16:15 ET

At the news

NEUTRALIMPACT 5/10

8-K filed Nov 13, 2026 at 16:15 ET

DataMEDS AI reported Q3 2026 revenue of $2.67 million, up 50% sequentially from Q2 2026's $1.78 million, and generated GAAP net income of $10.5 million ($2.72 diluted EPS) versus a $34.3 million loss a year ago, driven by a $19.1 million gain on debt extinguishment. The company also regained full Nasdaq compliance, launched the Health Lives Here app with NFL Alumni Health, and signed an MOU with a Florida HMO covering 25,000+ members. However, revenue declined 11.4% YoY from $3.01 million, and the net profit was entirely from non-operating debt gains, with a $3.4 million operating loss.

  • Q3 2026 revenue of $2,668,980, up 50% sequentially from Q2 2026's $1,779,860 but down 11.4% from $3,012,904 in Q3 2025
  • GAAP net income of $10,535,560 ($2.72 diluted EPS) vs net loss of $34,318,204 ($23.07 loss per share) in Q3 2025
  • Net income driven by $19,064,881 gain on extinguishment of debt; operating loss was $3,373,956
  • Cash and cash equivalents fell to $476,598 from $2,456,373 at June 30, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access